75833-38-4

Basic information

• Product Name: 2-Chloropyrimidine-4-carbonitrile
• Synonyms: 4-Pyrimidinecarbonitrile, 2-chloro- (7CI,9CI);2-Chloro-4-pyrimidinecarbonitrile;2-Amino-4-cyanopyrimidine;2-Chloro-4-cyanopyrimidine;2-chloro-4-cyanopyrmidine;2-ChloropyriMidine-4-carb...;4-PyriMidinecarbonitrile,2-chloro-;2-Chloro-4-cyanopyrimidine, 2-Chloro-4-cyano-1,3-diazine
• CAS NO: 75833-38-4
• Molecular Formula: C₅H₂ClN₃
• Molecular Weight: 139.54248
• Product Categories: PYRIMIDINE;pharmacetical;Building Blocks;Heterocycle-Pyrimidine series
• Mol File: 75833-38-4.mol
• Article Data: 9

Chemical Properties

• Melting Point: 53-55°
• Boiling Point: 331.279 °C at 760 mmHg
• Flash Point: 154.152 °C
• Appearance: /
• Density: 1.43
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.6
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -4.96±0.20(Predicted)
• CAS DataBase Reference: 2-Chloropyrimidine-4-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Chloropyrimidine-4-carbonitrile(75833-38-4)
• EPA Substance Registry System: 2-Chloropyrimidine-4-carbonitrile(75833-38-4)

Safety Data

• Hazard Codes: Xn
• Statements: 22-36/37/38
• Safety Statements: 26-36/37
• RIDADR: 3439
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 75833-38-4(Hazardous Substances Data)

Usage

Chemical Properties

Light yellow solid

Synthesis Reference(s)

Journal of Heterocyclic Chemistry, 1, p. 130, 1964 DOI: 10.1002/jhet.5570010305

InChI:InChI=1/C5H4N4/c6-3-4-1-2-8-5(7)9-4/h1-2H,(H2,7,8,9)

Upstream product

• 3934-20-1 2,6-Dichloropyrimidine 
• 75-86-5 2-hydroxy-2-methylpropanenitrile 
• 557-21-1 zinc(II) cyanide 
• 7460-56-2 2-hydroxy-pyrimidine-4-carbaldehyde oxime 
• 950514-12-2 2-hydroxy-4-pyrimidinecarboxaldehyde 
• 7460-56-2 2-oxo-1,2-dihydro-pyrimidine-4-carbaldehyde oxime 

Downstream Products

• 75825-52-4 2-(2-Methoxy-phenylamino)-pyrimidine-4-carbonitrile 
• 75825-53-5 2-(4-Dimethylamino-phenylamino)-pyrimidine-4-carbonitrile 
• 75825-59-1 2-methoxypyrimidine-4-carboxylic acid methyl ester 
• 79605-00-8 2-dimethylaminopyrimidine-4-carbonitrile 
• 75825-49-9 2-Diethylamino-pyrimidine-4-carbonitrile 
• 955112-52-4 tert-butyl (2-chloropyrimidin-4-yl)(methyl)carbamate 
• 943123-06-6 2-(3-ethoxyphenylamino)pyrimidine-4-carbonitrile 
• 943123-15-7 2-(3-(4-(4-methoxybenzyl)piperazin-1-yl)phenylamino)pyrimidine-4-carbonitrile 
• 149849-92-3 2‐chloropyrimidine‐4‐carboxylic acid 
• 1590359-14-0 C₁₂H₆F₃N₃ 
• 1216604-60-2 C₁₁H₇ClN₂O₂ 

Relevant articles and documents

Synthesis method of 2-chloropyrimidine-4-formic acid

The invention relates to a synthesis method of 2-chloropyrimidine-4-formic acid. 2, 4-dichloropyrimidine is used as a starting raw material, the target product 2-chloropyrimidine-4-formic acid is prepared through a two-step reaction, and the whole synthesis process is high in yield, the purity is good, and the operation is convenient, green and environmentally friendly, therefore the method is suitable for industrial production.

NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK

The present invention is concerned with substituted oxazole derivatives that selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant protein kinases implicated in a variety of human and animal diseases s

COMPOSITIONS AND METHODS FOR TREATING CANCER

The instant invention provides a method of treating a cancer, selected from the group consisting of breast cancer, melanoma, colorectal cancer, non-small cell lung cancer and ovarian cancer, by administering a combination of a WEE1 inhibitor and a CHK1 inhibitor, wherein the WEE1 inhibitor is MK-1775 or a pharmaceutically acceptable salt thereof, or MK-3652 or a pharmaceutically acceptable salt thereof, and the CHK1 inhibitor is MK-8776 or a pharmaceutically acceptable salt thereof, or SCH900444 or a pharmaceutically acceptable salt thereof.